Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Equity Ratio (2019 - 2026)

Biodesix filings provide 8 years of Equity Ratio readings, the most recent being 0.1 for Q1 2026.

  • On a quarterly basis, Equity Ratio fell 24.76% to 0.1 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.1, a 24.76% decrease, with the full-year FY2025 number at 0.03, down 113.13% from a year prior.
  • Equity Ratio hit 0.1 in Q1 2026 for Biodesix, up from 0.03 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.31 in Q2 2024 to a low of 0.09 in Q2 2023.
  • Median Equity Ratio over the past 5 years was 0.06 (2023), compared with a mean of 0.08.
  • The widest YoY moves for Equity Ratio: up 1727.28% in 2024, down 212.04% in 2024.
  • Biodesix's Equity Ratio stood at 0.22 in 2022, then tumbled by 79.16% to 0.05 in 2023, then skyrocketed by 364.49% to 0.21 in 2024, then crashed by 113.13% to 0.03 in 2025, then skyrocketed by 442.43% to 0.1 in 2026.
  • The last three reported values for Equity Ratio were 0.1 (Q1 2026), 0.03 (Q4 2025), and 0.02 (Q3 2025) per Business Quant data.